INFertility Therapy in obese patients: modern trends

Close metadata

Recommended articles:

Serum uric acid — a metabolic marker of non-alcoholic fatty liver disease. Russian Journal of Evidence-Based Gastroenterology. 2024;(2):36-42

Assessment of the condition of organs and tissues of the oral cavity in people with dentition defects against the background of metabolic syndrome. Stomatology. 2024;(3):31-38

Experience of combined treatment of patients with infertility operated for external genital endometriosis. Russian Bulletin of Obstetrician-Gynecologist. 2024;(3):77-81

Predicting the risk of decreased ovarian reserve after surgical treatment of patients with deep infiltrative endometriosis using artificial intelligence. Russian Bulletin of Obstetrician-Gynecologist. 2024;(3):92-102

A personalized application of therapeutic physical factors in patients with metabolic syndrome. Regenerative Biotechnologies, Preventive, Digital and Predictive Medicine. 2024;(2):5-11

Skin alterations as possible clinical markers of diabetes mellitus and metabolic syndrome. Russian Journal of Preventive Medicine. 2024;(7):101-107

Cognitive impairments and emotional disorders and their correction in perimenopausal women. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):48-53

Correlation dependence of tissue inhibitor of metalloproteinase-1 levels and follicular fluid morphology in patients with combined (uterine myoma and endometriosis) infertility in the ART-programs. Russian Bulletin of Obstetrician-Gynecologist. 2024;(4):21-28

Condition of the vascular wall and uric acid level in men with low and moderate cardiovascular risk depending on body mass index. Russian Journal of Preventive Medicine. 2024;(8):66-72

Clinical consequences of sarcopenic obesity. Part 1. Non-alcoholic fatty liver disease, type 2 diabetes mellitus, chronic kidney disease. Russian Journal of Preventive Medicine. 2024;(8):114-120

The problem of infertility treatment in patients with obesity is discussed. Results of original studies, metaanalysis and systematic reviews are presented.

Keywords:

infertility

obesity

metabolic syndrome

metformi

Authors:

Podzolkova N.M.

Kafedra akusherstva i ginekologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia, Moskva

Koloda Iu.A.

Kafedra akusherstva i ginekologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia, Moskva

Podzolkov A.V.

Kafedra éndokrinologii Pervogo MGMU im. I.M. Sechenova

List of references:

Sukhikh G.T., Nazarenko T.A. (red). Besplodnyi brak. Sovremennye podkhody k diagnostike i lecheniyu. M: GEOTAR-Media 2010; 784.
Blagosklonnaya L.V., Krasil'nikova E.I., Babenko A.Yu. Ozhirenie i ego potentsial'naya rol' v razvitii metabolicheskogo sindroma. Novye Sankt-Peterburgskie vrachebnye vedomosti 1998; 4: 6: 43-48.
Gevorkyan M.A., Manukhin I.B., Tumilovich L.G. Klinicheskie lektsii po ginekologicheskoi endokrinologii. M: GEOTAR-Media 2006; 234.
Roitenberg G.E. (red.). Metabolicheskii sindrom. M: Med-press-inform 2007; 224.
Dedov I.I., Mel'nichenko G.A.(red.) Ozhirenie: etiologiya, patogenez, klinicheskie aspekty. M: MIA 2004; 449.
Podzolkova N.M., Anshina M.B., Shamugiya N.L., Ablyaeva E.Sh., Koloda Yu.A. Vliyanie massy tela na effektivnost' programm vspomogatel'nykh reproduktivnykh tekhnologii. Mezhdunarodnyi kongress po reproduktivnoi meditsine "Reproduktivnoe zdorov'e i planirovanie sem'i", 2-i: Materialy. M 2008; 366.
Dedov I.I., Andreeva E.N., Pishchulin A.A., Karpova E.A. Sindrom giperandrogenii u zhenshchin. M 2006; 40.
Dedov I.I., Mel'nichenko G.A. (red.). Sindrom polikistoznykh yaichnikov. M: MIA 2007; 242-272.
Krasnopol'skii V.I., Logutova L.S., Serova O.F., Tuanova V.A., Zarochentseva N.V., Pozdnyakova T.I. Sindrom polikistoznykh yaichnikov. M: Adamant''; 40.
Abu Hashim H., El Lakany N., Sherief L. Combined metformin and clomiphene citrate versus laparoscopic ovarian diathermy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a randomized controlled trial. J Obstet Gynaecol Res 2011; 37: 3: 169-177.
Al-Azemi M., Omu F.E., Omu A.E. The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome. Arch Gynecol Obstet 2004; 270: 205-210.
Batukan C., Baysal B. Metformin improves ovulation and pregnancy rates in patients with polycystic ovary syndrome. Arch Gynecol Obstet 2001; 265: 124-127.
Cheng J., Lv J., Li C.Y., Xue Y., Huang Z., Zheng W. Clinical outcomes of ovulation induction with metformin, clomiphene citrate and human menopausal gonadotrophin in polycystic ovary syndrome. J Int Med Res 2010; 38: 4: 1250-1258.
Costello M.F., Chapman M., Conway U. A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome. Hum Reprod 2006; 21: 6: 1387-1399.
De Leo V., Musacchio M.C., Piomboni P., Di Sabatino A., Morgante G. The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications. Eur J Obstet Gynecol Reprod Biol 2011; 157: 1: 63-66.
Ehrmann D.A., Cavaghan M.K., Imperial J. et al. Effects of metformin on insulin secretion, insulin action and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82: 524-530.
Farquhar C., Gillett W. Prioritising for fertility treatments-should a high BMI exclude treatment? BJOG 2006; 113: 1107-1109.
Fedorcsak P., Dale P.O., Storeng R., Abyholm T., Tanbo T. The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: an open-label randomized cross-over trial. Gynecol Endocrinol 2003; 17: 3: 207-214.
Fedorcsák P., Storeng R., Dale PO, Tanbo T., Torjesen P., Urbancsek J., Abyholm T. Leptin and leptin binding activity in the preovulatory follicle of polycystic ovary syndrome patients. Scand J Clin Lab Inv 2000; 60: 8: 649-655.
Fulghesu A.M., Villa P., Pavone V. et al. The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82: 644-648.
Gilbert C., Valois M., Koren G. Pregnancy outcome after first-trimester exposure to metformin: a metaanalysis. Fertil Steril 2006; 86: 3: 658-663.
Hollmann M. Impact of waist-hip-ratio and body-mass-index on hormonal and metabolic parameters in young, obese women. Int J Obes Relat Metab Dis 1997; 21: 6: 476-483.
Hugues J.N. Impact of overweight on the outcome of ovarian stimulation. Bull Acad Natl Med 2008; 192: 4: 661-670.
Kjotrod S.B., von During V. Carlsen. Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome: a prospective, randomized, double blind study. Human Reprod 2004; 19: 1315-1322.
Legro R.S., Barnhart H.X., Schlaff W.D. Clomiphen, metformin, or both, for infertility in the polycystic ovary syndrome. NEJM 2007; 356: 551-566.
Li M., Song J., Chen S.L. Association of the clinical characteristics and the IVF-ET outcome in infertile women with polycystic ovarian syndrome of different subtypes. Nan Fang Yi Ke Da Xue Xue Bao 2009; 29: 2: 224-227.
Li X.J., Yu Y.X., Liu C.Q., Zhang W., Zhang H.J., Yan B., Wang L.Y., Yang S.Y., Zhang S.H. Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis. Clin Endocrinol (Oxford) 2011; 74: 3: 332-339.
McCormick B., Thomas M., Maxwell R. Effects of polycystic ovarian syndrome on in vitro fertilization-embryo transfer outcomes are influenced by body mass index. Fertil Steril 2008; 90: 6: 2304-2309.
Moll E., Bosuyt P.M., Korevaar J.C., Lambalk C.B., van der Veen F. Effect of clomiphen citrate plus metormin and clomiphen citrate plus placebo on induction ovulation in women with newly diagnosed polycystic ovary syndrome: Randomized double-blind clinical trial. BMJ 2006; 332: 1485.
Moll E., van der Veen F., van Wely M. The role of metformin in polycystic ovary syndrome: a systematic review. Hum Reprod Update 2007;13: 6: 527-537.
Nieuwenhuis-Ruifrok A.E., Kuchenbecker W.K., Hoek A., Middleton P., Norman R.J. Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis. Hum Reprod Update 2009; 15: 1: 57-68.
Norman R.J., Noakes M., Wu R., Davies M.J., Moran L., Wang J.X. Improving reproductive performance in overweight/obese women with effective weight management. Hum Reprod Update 2004; 10: 267-280.
Onalan G., Pabuccu R., Goktolga U., Ceyhan T., Bagis T., Cincik M. Metformin treatment in patients with polycystic ovary syndrome undergoing in-vitro fertilization: a prospective, randomized trial. Fertil Steril 2005; 84: 798-801.
Palomba S., Orio F., Nardo L.G., Falbo A., Russo T., Corea D. Metformin administration versus laparoscopic ovarian diathermy in clomiphen citrate-resistant women with polycystic ovary syndrome: a prospective, randomized double-blind placebo-controlled trial. J Clin Endocrinol Metab 2004; 89: 4801-4809.
Pasquali R., Antenucci D., Casimirri F., Venturoli S., Paradisi R., Fabbri R. et al. Clinical and hormonal characteristics of obese and amenorrheic women before and after weight loss. J Clin Endocrinol Metab 1989; 68: 173-179.
Tang T., Granville J., Orsi N., Barth J.H., Balen A.H. The use of metformin for women with PCOS undergoing IVF treatment. Human Reprod 2006; 21: 1416-1425.
Tang T., Lord J.M., Norman R.J., Yasmin E., Balen A.H. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev 2010; 20: 1: CD003053.
Tso L.O., Costello M.F., Albuquerque L.E., Andriolo R.B., Freitas V. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome. Cochrane Database Syst Rev 2009; 2: CD006105.
Wass P., Waldenstrom U., Rossner S. et al. An android body fat distribution in females impairs the pregnancy rate of in-vitro fertilization-embryo transfer. Hum Reprod 1997; 12: 2057-2060.

Close metadata